| TNBC | Triple-negative breast cancer |
| ER | Estrogen receptor |
| PR | Progesterone receptor |
| HER2 | Human epithelial growth factor receptor 2 |
| PARP | Poly ADP ribose polymerase |
| BL1 | Basal-like 1 |
| BL2 | Basal-like 2 |
| IM | Immunomodulatory |
| M | Mesenchymal |
| MSL | Mesenchymal stem-like |
| LAR | Luminal androgen receptor |
| EMT | Epithelial–mesenchymal transition |
| OS | Overall survival |
| DFS | Disease-free survival |
| ABCC9 | ATP-binding cassette subfamily C member 9 |
| NKAPL | NF-Kβ-activating protein-;ike |
| MiRNA | MicroRNA |
| ARRB1 | Arrestin beta 1 |
| lncRNA | Long non-coding RNA |
| DNMT3A | DNA methyltransferase 3α |
| EZH2 | Enhancer of zeste homolog 2 |
| PKM2 | Pyruvate kinase M2 |
| EGFR | Epidermal growth factor receptor |
| VEGF | Vascular endothelial growth factor |
| PD-L1 | Programmed death ligand-1 |
| TIL | Tumor infiltrating lymphocyte |
| ITPKC | Inositol 1,4,5-trisphosphate 3-kinase C |
| CTC | Circulating tumor cell |
| cfDNA | Circulating cell-free DNA |
| ctDNA | Circulating tumor DNA |
| EVs | Extracellular vesicles |
| IGF-IR | Insulin-like growth factor 1 receptor (IGF-IR) |
| MMP-2 | Matrix metalloproteinase-2 |
| MMP-9 | Matrix metalloproteinase-9 |
| LAG-3 | Lymphocyte activation gene 3 |
| IHC | Immunohistochemistry |
| TIM-3 | T-cell immunoglobulin and mucin-domain containing protein 3 |
| TCGA | The Cancer Genome Atlas |